Atlas Trials

Lung Squamous Cell Carcinoma

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lung Squamous Cell Carcinoma

RecordFirmDate
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma (NCT05024266)First Affiliated Hospital of Zhejiang University2021-08-01
Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04267913)SWOG Cancer Research Network2020-09-05
Identify Prognostic Biomarkers of Lung Cancer (NCT05010330)RenJi Hospital2020-07-01
Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma (NCT07147361)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2020-05-28
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers (NCT06255197)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2019-11-04
To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation (NCT04132102)Shanghai Chest Hospital2018-11-27
Apatinib for Advanced Lung Squmamous Carcinoma (NCT03725423)Xuzhou Central Hospital2018-10-01
Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma (NCT02876978)CARsgen Therapeutics Co., Ltd.2016-03-01
Oral Rigosertib for Squamous Cell Carcinoma (NCT01807546)Traws Pharma, Inc.2013-03-01
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01386385)National Cancer Institute (NCI)2011-06-20
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT00334815)National Cancer Institute (NCI)2006-06-15

Track Lung Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.